Innovative treatment project recognised at national health awards

The Norfolk and Norwich Hospital’s Urology department have been highly commended at the HSJ Value Awards 2018.

The commendation, which was presented at the annual awards ceremony in Manchester, recognised the hospital’s innovative work introducing the Urolift procedure. The procedure, which is a minimally-invasive ambulatory treatment for severe urinary tract symptoms from benign prostate hyperplasia (BPH), has meant rapid symptom relief and quicker recovery for patients.

Each year around 400 surgical treatments are undertaken at NNUH to treat severe urinary tract symptoms from benign prostate hyperplasia (BPH). Traditional surgical treatments often require general anaesthetic and mean longer stays in hospital for patients. The new state of the art treatment was introduced at NNUH in 2016 and has broadened patient choice and has helped to significantly improve quality of life for patients suffering with BPH.

Mr Mark Rochester, NNUH Urology Consultant, said: We’re thrilled to have been highly commended in the ‘Improving Surgical Services’ category at this year’s HSJ Value awards. Developments in treatments for these patients are advancing rapidly and we’re delighted to be at the forefront of care provision in this respect.”

Richard Parker, Chief Operating Officer added: “Through this innovative project our Urology team have delivered huge benefits for our patients as well as fuelling efficiency in the way we manage our resources including surgical capacity at NNUH. I’d like to congratulate the team on their hard work and this very well-deserved national recognition.”

Members of the NNUH Urology team